Beta-lactamase

Beta-lactamase is a type of enzyme that plays a critical role in bacterial resistance to antibiotics, specifically those antibiotics that fall within the beta-lactam class. This class includes some of the most commonly used antibiotics, such as penicillins, cephalosporins, monobactams, and carbapenems. Beta-lactamase enzymes work by breaking the beta-lactam ring that is central to the molecular structure of these antibiotics, thereby neutralizing their antibacterial effect.

Mechanism of Action

Beta-lactamase enzymes achieve their effect by hydrolyzing the beta-lactam ring within the antibiotic molecule. This hydrolysis reaction effectively inactivates the antibiotic, preventing it from binding to its target penicillin-binding proteins (PBPs) located in the bacterial cell wall. The PBPs are essential for the synthesis of the cell wall in bacteria, and their inhibition by beta-lactam antibiotics leads to cell lysis and death. However, the presence of beta-lactamase can confer resistance to bacteria against these antibiotics.

Classification

Beta-lactamases are classified into several groups based on their substrate specificity and response to inhibitors. The two main classification systems are the Ambler classification and the Bush-Jacoby-Medeiros classification.

Ambler Classification

The Ambler classification divides beta-lactamases into four classes (A, B, C, and D) based on their protein sequences:

• Class A, C, and D enzymes are serine beta-lactamases.
• Class B enzymes are metallo-beta-lactamases that require zinc for their activity.

Bush-Jacoby-Medeiros Classification

The Bush-Jacoby-Medeiros system classifies beta-lactamases based on their functional characteristics, including substrate profile and inhibitor susceptibility. This system identifies three major groups:

• Group 1 includes cephalosporinases that are not inhibited by clavulanic acid.
• Group 2 consists of penicillinases, cephalosporinases, and broad-spectrum beta-lactamases, many of which are inhibited by clavulanic acid.
• Group 3 includes metallo-beta-lactamases, which are not inhibited by clavulanic acid or other beta-lactamase inhibitors.

Clinical Significance

The production of beta-lactamase is a major mechanism of resistance to beta-lactam antibiotics among bacteria. This has led to significant clinical challenges, as infections caused by beta-lactamase-producing bacteria are more difficult to treat. In response, beta-lactamase inhibitors such as clavulanic acid, sulbactam, and tazobactam have been developed and are often used in combination with beta-lactam antibiotics to overcome resistance.

Detection and Testing

Laboratory detection of beta-lactamase production is crucial for the appropriate selection of antibiotics in the treatment of bacterial infections. Various methods, including the nitrocefin disk test, the modified Hodge test, and molecular techniques, are used to detect the presence of beta-lactamase enzymes in bacterial isolates.

Conclusion

Beta-lactamase production by bacteria is a significant mechanism of antibiotic resistance, particularly against the beta-lactam class of antibiotics. Understanding the various types of beta-lactamases, their mechanisms of action, and methods of detection is essential for the development of effective treatment strategies against resistant bacterial infections.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian